img-interior

WWFH Champions Class of 2016

Each year, employees who have gone outside their job description as advocates for the biopharmaceutical industry are recognized as Champions. Our 2016 honorees are 13 individuals who come from a variety of disciplines. They not only excel in their everyday roles, but also as advocates for our industry. Learn more about these remarkable Champions below:

Joseph LatellaJospeh Latella
Senior Regional Specialty Sales Manager
Astellas Pharma US

Joseph (Joe) is a passionate PAC Ambassador and an active student of health care policy. He is a member of the St. Elizabeth's Hospital Foundation Board and brings a trusted perspective on the implications of evolving policies on physicians, patients and the hospital. 

 

Juan Nadal, MDJuan Nadal, MD
Vice President, Medical Communications
Bayer Corporation

Dr. Nadal is an advocate for health professionals and patients. A champion for clinical pharmacists, Juan has been instrumental in Bayer's PharmD Fellowship program with Rutgers University, which enables new PharmD's to have a better inside view of the biopharmaceutical industry. 

 

J. Aaron GrahamJ. Aaron Graham
Executive Director, Brand Safety and Security
Boehringer Ingelheim

Aaron has engaged with Congressional members and the FDA on outreach to Hispanic groups about the dangers of purchasing counterfeit medications from unauthorized retailers. He also advocates on drug take-back programs, anti-counterfeiting and protection of BI’s extensive supply chain. 

 

Adam TaliaferroAdam Taliaferro
Associate Director, State Strategy & Policy
Bristol-Myers Squibb

After his workday is over, Adam not only represents his hometown in the New Jersey state legislature, he is also an advocate for patients and the health care industry through his foundation. The Adam Taliaferro Foundation provides emotional, financial and educational support to individuals who suffer catastrophic head or spinal injuries and supports the research, prevention, and care of such injuries.

 

Michele SchmidtMichele Schmidt. RN
Executive Director, Global Project Leadership
Celgene

As a “Celgene Ambassador," Michele has been a tremendous partner to the Government Relations teams in helping them understand and communicate Celgene's clinical trials footprint to legislators across the United States. She helped create the first Celgene State Fact Sheets to demonstrate Celgene's presence in states across the country – an important tool as we discuss the impact of the biopharmaceutical industry.

 

Pauline CoderrePauline Coderre, RPh, MS, CCP
Health Education Consultant
Eli Lilly and Company

Pauline is a true patient advocate who believes in going beyond medicine to engage, educate and empower patients to be active in their own health care and improve overall outcomes. She identifies new ways to provide patients with timely, action-oriented resources on health and wellness and a variety of disease states.

 

Christine SchnackenbergChristine Schnackenberg, PhD, FAHA
Senior Scientific Investigator
GlaxoSmithKline

Dr. Schnackenberg chairs GSK's Science in the Schools group in Upper Merion, PA. This volunteer group works to provide opportunities for GSK employees to share science in their local communities and inspire future generations of scientists.

 

Norris TurnerNorris Turner Jr., PharmD, PhD
Therapeutic Area Director, Healthcare Quality Systems, Strategic Customer Group
Janssen Pharmaceutical Companies of Johnson & Johnson

Norris helps develop and drive programs aimed at elevating the standard of care for those with serious mental illness. Through legislative advocacy and community outreach, he champions policy solutions and population health management strategies that support earlier treatment interventions and enhanced collaboration between the mental health and criminal justice systems.

 

Marilyn MainardiMarilyn Mainardi
Associate Director, Market Access, USP Pricing and Reimbursement
Merck

As Merck's national representative for the Merck Patient Assistance Program, Marilyn has been instrumental in supporting Merck's core value of expanding access to medicines and vaccines. She embodies the underlying principles of the program by always remembering it is about ensuring patients have access to the medicines they need to improve their health and well-being.

 

Nancy BellNancy Bell, PharmD
Medical Outcomes Specialist
Pfizer

Dr. Bell works with insurers and large health care delivery systems to improve the quality of health care. Dr. Bell works extensively with the Iowa Pharmacy Association and her alma mater, Drake University, to shape the profession of pharmacy and relations with the pharmaceutical industry to improve health care in her state. She has worked with various advocacy groups on smoking cessation policies and efforts and has also been appointed to a statewide task force addressing opioid and heroine abuse.
 

Jayaram SrirangamJayaram Srirangam, PhD, MBA
Associate Research Fellow in Worldwide PharmSci
Pfizer

For more than 20 years, Jay has been a passionate advocate for the industry. Whether it’s shoe-leather lobbying or discussing how the industry is addressing life-threatening diseases at TEDx or the Society of Asian Scientists and Engineers at UCSD, he is a tireless champion for Pfizer and for the industry.

 

Diana LenkowskyDiana Lenkowsky
Vice President, Facilities and Administrative Services
Purdue Pharma

Diana has for decades been the "face of Purdue" in the community around its Connecticut headquarters. Diana sits on more than 10 agency boards, coordinates financial and in-kind support to more than 60 community groups, and last year she coordinated the attendance of 200 Purdue colleagues at more than 20 community fundraising events.

 

Alok GoelAlok Goel
Senior Manager, HR Operations & Special Projects
Sanofi US

Alok has a passion for grassroots, civic engagement and health care policy. Al is one of the first to take action when employees are asked to make their voices heard by Congress. He has frequently visited legislators in their districts and even on Capitol Hill. In doing so, Al always draws on his experience to advocate for the biopharmaceutical industry and the patients it serves.


 

Back to listing